Showing results (1471-1480 of 1,728) with videos related to
Sort By:
Pageof 173
Transactions of the Royal Society of Tropical Medicine and Hygiene|September 1, 1995
Treatment of snake bites by Bothrops species and Lachesis muta in Ecuador: laboratory screening of candidate antivenomsR D Theakston, G D Laing, C M Fielding, et al.The Journal of Clinical Investigation|March 15, 1996
Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosisJ Zabner, B W Ramsey, D P Meeker, et al.Pharmacopsychiatry|June 24, 2014
Baseline vitamin B12 and folate levels do not predict improvement in depression after a single infusion of ketamineN B Lundin, M J Niciu, D A Luckenbaugh, et al.British Journal of Haematology|February 13, 2001
Progressive reduction in treatment-related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI)D R Hargrave, I I Hann, S M Richards, et al.The International Journal of Neuropsychopharmacology|December 25, 2014
Ketamine's antidepressant efficacy is extended for at least four weeks in subjects with a family history of an alcohol use disorderMark J Niciu, David A Luckenbaugh, Dawn F Ionescu, et al.Aquatic Toxicology (Amsterdam, Netherlands)|September 29, 2004
Microcosm evaluation of the effects of an eight pharmaceutical mixture to the aquatic macrophytes Lemna gibba and Myriophyllum sibiricumRichard A Brain, David J Johnson, Sean M Richards, et al.British Journal of Cancer|February 1, 1994
Molecular genetic investigation of sporadic renal cell carcinoma: analysis of allele loss on chromosomes 3p, 5q, 11p, 17 and 22K Foster, P A Crossey, P Cairns, et al.Cancer|January 1, 1995
A phase III randomized, double-blind multiinstitutional trial of vaccinia melanoma oncolysate-active specific immunotherapy for patients with stage II melanomaM K Wallack, M Sivanandham, C M Balch, et al.Therapeutic Advances in Chronic Disease|May 9, 2015
Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective reviewNicolas D Iadarola, Mark J Niciu, Erica M Richards, et al.Plos One|February 28, 2019
Correction: Low-cost cross-taxon enrichment of mitochondrial DNA using in-house synthesised RNA probesStephen M Richards, Nelli Hovhannisyan, Matthew Gilliham, et al.Pageof 173